Denis Chem Lab Share Price | Denis Chem Lab Stock Screener
DENISCHEM
Pharmaceuticals
Share Price BSE
₹70.31
▲
0.31 (0.44%)
As of May 21, 2026, the Denis Chem Lab share price (BSE: DENISCHEM) is ₹70.31, up 0.44% from the previous close, with shares trading between ₹69.99 and ₹72.90, and a 52-week range of ₹56.54–₹113.75.
Check DENISCHEM 52-week chart for the annual price range and momentum.
Use the Denis Chem Lab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Denis Chem Lab Market Cap
₹101.04 Cr.
DENISCHEM P/E Ratio (TTM)
11.97
Denis Chem Lab P/B Ratio
1.19
EPS (TTM)
₹5.82
Dividend Yield
2.00%
Debt to Equity
0.01
DENISCHEM 52 Week High
₹113.75
Denis Chem Lab 52 Week Low
₹56.54
Operating Margin
11.00%
Profit Margin
5.03%
DENISCHEM Revenue (TTM)
₹179.00
EBITDA
₹22.00
Net Income
₹9.00
Total Assets
₹112.00
Total Equity
₹85.00
Denis Chem Lab Share Price Chart
Screen Denis Chem Lab share price with an interactive chart. Analyse DENISCHEM price trends and volatility across different timeframes.
Denis Chem Lab Company Profile - Fundamental Screener
Screen Denis Chem Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DENISCHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE051G01012
Denis Chem Lab Balance Sheet Screener
Screen DENISCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 112 | 109 | 99 | 96 | 92 | 97 | 106 | 101 | 94 | 85 |
| Current Assets | 71 | 69 | 59 | 53 | 49 | 50 | 54 | 53 | 48 | 34 |
| Fixed Assets | 39 | 38 | 35 | 42 | 41 | 46 | 50 | 40 | 44 | 40 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 2 | 3 | 5 | 6 | 4 | 6 | 11 | 20 | 22 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 85 | 80 | 72 | 67 | 62 | 59 | 57 | 50 | 30 | 16 |
| Share Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 12 | 9 |
| Reserves & Surplus | 71 | 67 | 58 | 53 | 48 | 45 | 43 | 36 | 18 | 3 |
Denis Chem Lab Income Statement Screener - Profit & Revenue Analysis
Screen Denis Chem Lab income statement and profit fundamentals.
Analyze DENISCHEM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Denis Chem Lab share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 179 | 176 | 169 | 161 | 138 | 110 | 136 | 126 | 108 | 114 | 100 | 77 |
| Expenses | 157 | 157 | 147 | 142 | 122 | 99 | 121 | 110 | 95 | 100 | 91 | 68 |
| EBITDA | 22 | 19 | 23 | 19 | 15 | 11 | 15 | 16 | 13 | 15 | 9 | 10 |
| Operating Profit % | 11.00% | 9.00% | 13.00% | 12.00% | 11.00% | 9.00% | 11.00% | 11.00% | 11.00% | 12.00% | 9.00% | 12.00% |
| Depreciation | 5 | 7 | 7 | 8 | 6 | 6 | 7 | 6 | 6 | 7 | 6 | 4 |
| Interest | 4 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 6 | 7 | 5 |
| Profit Before Tax | 12 | 11 | 15 | 11 | 9 | 3 | 6 | 6 | 2 | 2 | -3 | 0 |
| Tax | 3 | 3 | 4 | 3 | 3 | 1 | 2 | 0 | 0 | 1 | 1 | 0 |
| Net Profit | 9 | 8 | 11 | 8 | 6 | 2 | 4 | 6 | 2 | 1 | -4 | 0 |
| EPS | 6.30 | 5.82 | 8.04 | 5.66 | 4.51 | 1.63 | 3.03 | 4.58 | 1.69 | 1.07 | -4.92 | 0.09 |
Denis Chem Lab Cash Flow Screener - Liquidity Fundamentals
Screen DENISCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | 18 | 16 | 17 | 8 | 13 | 8 | 11 | 7 | 21 |
| Investing Activities | -8 | -15 | -11 | -10 | -1 | -2 | -2 | -16 | -1 | -13 |
| Financing Activities | -4 | -4 | -4 | -7 | -6 | -14 | -5 | 1 | 0 | -7 |
| Net Cash Flow | 0 | -1 | 1 | 0 | 1 | -3 | 1 | -4 | 5 | 1 |
Denis Chem Lab Shareholding Pattern Screener
See Denis Chem Lab shareholding pattern with promoter, FII, and DII holdings.
Check Denis Chem Lab promoter holding and ownership changes for DENISCHEM on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 38.98% | 38.98% | 38.98% | 38.98% | 38.98% | 38.98% | 38.98% | 38.98% |
| FII Holding | 0.01% | 0.00% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 28.93% | 27.41% | 28.22% | 28.90% | 28.94% | 26.94% | 26.88% | 27.44% |
| Other Holding | 32.09% | 33.61% | 32.79% | 32.12% | 32.07% | 34.08% | 34.14% | 33.57% |
| Shareholder Count | 6,927 | 7,218 | 7,227 | 7,304 | 7,102 | 4,834 | 6,021 | 6,857 |
Denis Chem Lab Share Dividend Screener - Share Yield Analysis
Check Denis Chem Lab dividend history with payout and yield data.
View Denis Chem Lab dividend details including ex-dates and amounts for DENISCHEM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 2.65% |
| 2024-March | ₹2.50 | 2.70% |
| 2023-March | ₹2.00 | 1.33% |
| 2022-March | ₹1.50 | 2.36% |
| 2021-March | ₹0.75 | 1.10% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 3.37% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Denis Chem Lab Stock Index Membership
See which indices include Denis Chem Lab stock.
Check DENISCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Denis Chem Lab Market Events Screener - Corporate Actions
Get Denis Chem Lab corporate actions including splits, bonuses, and buybacks.
Check Denis Chem Lab stock events that may affect DENISCHEM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.50 /share | -11.78% | ||
| Dividend | ₹ 0.75 /share | -3.52% | ||
| Dividend | ₹ 1.50 /share | 33.33% | ||
| Dividend | ₹ 2.00 /share | 34.35% | ||
| Dividend | ₹ 2.50 /share | -9.03% | ||
| Annual General Meeting | NA | -7.95% | ||
| Rights | 2:11 | - | ||
| Annual General Meeting | NA | -2.69% | ||
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 0.29% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -3.12% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -4.71% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 4.32% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -10.11% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.16% |
Denis Chem Lab Competitors Screener - Peer Comparison
Screen DENISCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Denis Chem Lab Company Announcements - News Screener
Screen DENISCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-13 | Announcement Under Regulation 30 (LODR) - Revised- Intimation Of Resignation Of Secretarial Auditors. | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-12 | Announcement Under Regulation 30 (LODR) - Updates (Intimation Of Resignation Of Secretarial Auditors) | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-04-10 | Announcement Under Regulation 30 (LODR) - Updates ( Reply To Clarification Of Price Movement. | - |
| 2026-04-10 | Clarification sought from Denis Chem Lab Ltd | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-30 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-30 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-23 | Closure of Trading Window | - |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Results-Financial Results For December 31 2025 | - |
| 2026-02-14 | Board Meeting Outcome for Submission Of Unaudited Financial Results For The Quarter Ended On 31St December 2025 | - |
| 2026-02-04 | Board Meeting Intimation for Taking On Record Unaudited Financial Results For The Quarter Ended On 31St December 2025 | - |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-12 | Closure of Trading Window | - |
| 2025-11-13 | Results - Financial Results For Sep 30 2025 | - |
| 2025-11-13 | Board Meeting Outcome for Board Meeting Outcome For - Submission Of Un-Audited Financial Results For The Quarter Ended On 30Th September 2025 | - |